HTA48 Minimum Follow-up Time Required for the Detection of the Impact of Treatments on Neuropathic Pain and Gastrointestinal Complaints in Fabry Disease
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1180
https://www.valueinhealthjournal.com/article/S1098-3015(22)01381-X/fulltext
Title :
HTA48 Minimum Follow-up Time Required for the Detection of the Impact of Treatments on Neuropathic Pain and Gastrointestinal Complaints in Fabry Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01381-X&doi=10.1016/j.jval.2022.04.1180
First page :
Section Title :
Open access? :
No
Section Order :
11056